Kevin Harrod, Ph.D.

Home
Research & Reports
About Our Research
Meet the Researchers
Kevin Harrod, PhD

Research Project:
Novel SARS-CoV-2 antivirals targeting viral encoded ion channels

Grant Awarded:

COVID-19 Respiratory Virus Research Award

Research Topic:

combination therapies experimental therapeutics

Research Disease:

COVID-19

Despite the rapid deployment of vaccines that offer protective immunity, immunizations will not eradicate SARS-CoV-2, and break through infections will occur. Thus, therapeutic interventions and particularly antivirals will be critical in the postimmunization era of COVID-19. This application will use a high throughput drug screening platform to identify and repurpose already FDA approved drugs that may interfere with normal viral replication and could be used to blunt viral infections of the lung.

Page last updated: September 22, 2022

Join the Patient & Caregiver Network

End Youth Vaping

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Events Near You

Kevin Harrod, PhD

We Need Your Help

Make a Donation

Sign Up for Email Updates

Select Your Location

Change Language

Call Our HelpLine

1-800-LUNG-USA